The world is facing a severe cancer workforce crisis, with experts warning of a shortage of 100 million staff by 2050, as 100,000 people are diagnosed every day. Patients could face significantly longer waits for diagnosis and treatment as the global cancer burden continues to rise, threatening to overwhelm healthcare systems, according to a report presented at the world’s largest oncology conference.
Projected Shortfall of 100 Million Workers
Research presented at the American Society of Clinical Oncology’s annual meeting in Chicago reveals a projected shortfall of 100 million cancer care workers by 2050. The largest gaps are expected in nursing, with about 65 million missing, and diagnostic staff, with a shortfall of around 16 million.
Rising Cancer Incidence
The workforce crisis coincides with a predicted 21% increase in cancer incidence, the report states. The rate is set to rise from 165 per 100,000 people in 2025 to 200 per 100,000 in 2050. Globally, about 20 million people are diagnosed with cancer each year, but by 2050 that figure could exceed 35.3 million, equivalent to nearly 100,000 diagnoses daily, according to the report published in The Lancet.
Urgent Wake-Up Call
Speaking at the report’s launch in Chicago, co-author Mark Lawler, a professor of digital health at Queen’s University Belfast, described the findings as “sobering”. He said: “The predicted 35 million cancer cases each year globally is in sharp contrast to the projected global shortfall of 100 million cancer care workers by 2050. Make no mistake, this is a wake-up call, no matter where you are in the world. What we’ve uncovered is shocking – how can we reconcile a 15 million increase in cancer cases with a 100 million decrease in cancer staffing? The data unfortunately do not lie. We can’t wait until 2050 to see if our projections are correct – we must act now.”
Diagnosis Challenges
Diagnosing all cancer patients is already a significant global problem. Without a diagnosis, patients are much less likely to survive. The report projects as many as 18.5 million cancer deaths annually by 2050. Currently, one in three cancer cases worldwide are undiagnosed, with up to 60% of people with cancer undiagnosed in some parts of Africa.
In high-income countries, cancer survival has substantially increased in recent decades, mainly due to new treatments and improvements in early detection. While survival in these countries is predicted to exceed 60% by 2050, the workforce crisis will also affect them, compromising their ability to improve outcomes.
Recommendations for Action
Co-lead author Dr. Hedvig Hricak, chair emeritus at Memorial Sloan Kettering Cancer Center in New York, said: “Our global initiative brings a clear warning: without urgent action to address critical workforce shortages, we risk a cancer crisis unlike anything we’ve seen before. We call for immediate, country-specific strategies, smarter workforce use, task-shifting and AI/digital health adoption, alongside future-ready education and strong, sustainable financing through public-private partnerships.”
The report offers several recommendations to address the projected staff shortage, including implementing national cancer control plans that embed workforce development, investing in technology, education and retention, expanding regional and international partnerships, and providing adequate funding for these long-term efforts.
Economic and Life-Saving Benefits
Investing in the cancer workforce now could avert 170 million cancer deaths between 2030 and 2050 and deliver approximately $120 trillion (£89 trillion) in net economic benefits, according to the report.
Another co-author, Dr. Peter Kingham, director of Memorial Sloan Kettering’s global cancer research and training programme, emphasised the importance of cancer prevention, such as promoting healthier diets and countering sedentary lifestyles. However, he stressed that urgent action to tackle the workforce crisis is essential, given the growing and ageing global population means more people will develop cancer than ever before.
“Cancer is fundamentally a disease of ageing,” he said. “As global life expectancy rises and conditions such as HIV are managed as chronic rather than terminal illnesses, more people worldwide are living long enough to face a cancer risk. This demographic shift is not a failure – it reflects remarkable progress in global health, but it demands an equally ambitious response in cancer care.”
